Status:
UNKNOWN
Acetic Acid Colonoscopy Enhancement Study
Lead Sponsor:
Istituto Clinico Humanitas
Collaborating Sponsors:
Nuovo Regina Margherita Hospital
Conditions:
Colorectal Cancer
Serrated Adenomas
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the additional diagnostic yield obtained by using the acetic acid as vital substance to improve the detection of serrated lesions at colonoscopy. Patients who ...
Eligibility Criteria
Inclusion
- The patient is \>40 years old
- The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;
- The patient must understand and provide written consent for the procedure.
Exclusion
- Patients with a history of colonic resection;
- Patients with inflammatory bowel disease;
- Patients with a personal history of polyposis syndrome;
- Patients with suspected chronic stricture potentially precluding complete colonoscopy;
- Patients with diverticulitis or toxic megacolon;
- Patients with a history of radiation therapy to abdomen or pelvis;
- Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2015
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02231385
Start Date
September 1 2014
End Date
June 1 2015
Last Update
September 4 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nuovo Regina Margherita Hospital
Rome, Italy, 00153
2
Humanitas Research Hospital
Rozzano, Milan, Italy, 20089